Lévodopa/Bensérazide Teva (Benserazide Hydrochloride, Levodopa)

Levodopa serves as a precursor that is converted to dopamine inside the brain, replenishing depleted neurotransmitter levels. Benserazide blocks the peripheral enzyme that would otherwise convert levodopa to dopamine outside the central nervous system, thereby increasing the amount that reaches the brain and reducing peripheral side effects.

The exact dose is individualized and set by the prescribing clinician based on disease severity, patient age, and response to therapy. Dosage adjustments are made during treatment to balance symptom control with tolerability, and patients should follow their healthcare provider's instructions.

Safety data for levodopa/benserazide in pregnancy and lactation are limited. The product is classified as having an unknown pregnancy category, and use is generally reserved for situations where the potential benefit outweighs potential risks. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their physician.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Compared with levodopa alone, the addition of benserazide improves central delivery of levodopa and reduces peripheral adverse effects such as nausea. Relative to dopamine agonists, levodopa/benserazide generally offers stronger symptomatic control but may be associated with motor complications like dyskinesia over long‑term use.

Store the tablets at ambient temperature, preferably below 25 °C, in the original blister pack or container. Protect them from moisture, excessive heat, and direct sunlight. Keep the product out of reach of children and do not use if the packaging is damaged.

The medication is taken orally with a glass of water. It can be taken with or without food, but high‑protein meals may interfere with absorption, so clinicians often advise spacing the dose from protein‑rich foods. Swallow tablets whole; do not crush or chew unless specifically instructed.

Serious adverse events include neuroleptic malignant‑like syndrome, which presents with high fever, muscle rigidity, and autonomic instability, and cardiac arrhythmias. Severe dyskinesia and psychiatric disturbances such as hallucinations may also occur, especially at higher doses or with rapid dose escalation.

Patients with known hypersensitivity to levodopa, benserazide, or any excipients should avoid the product. It is contraindicated in individuals taking non‑selective MAO inhibitors, those with narrow‑angle glaucoma, and patients with severe hepatic impairment. Clinicians must evaluate each case for additional contraindications.